Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G H Hendrix

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Circulation|July 1, 1987
Psychophysiologic factors in hypertensionJ A Herd, B Falkner, D E Anderson, et al.
Journal of the South Carolina Medical Association (1975)|December 1, 1996
Cardiac transplantation in South Carolina: the first 100 patientsA J Crumbley, A B Van Bakel, J R Handy, et al.
Circulation|November 14, 2001
Acute hemodynamic effects of conivaptan, a dual V(1A) and V(2) vasopressin receptor antagonist, in patients with advanced heart failureJ E Udelson, W B Smith, G H Hendrix, et al.
The New England Journal of Medicine|July 15, 1993
Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study GroupA M Feldman, M R Bristow, W W Parmley, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Circulation|July 1, 1987
Psychophysiologic factors in hypertensionJ A Herd, B Falkner, D E Anderson, et al.
Journal of the South Carolina Medical Association (1975)|December 1, 1996
Cardiac transplantation in South Carolina: the first 100 patientsA J Crumbley, A B Van Bakel, J R Handy, et al.
Circulation|November 14, 2001
Acute hemodynamic effects of conivaptan, a dual V(1A) and V(2) vasopressin receptor antagonist, in patients with advanced heart failureJ E Udelson, W B Smith, G H Hendrix, et al.
The New England Journal of Medicine|July 15, 1993
Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study GroupA M Feldman, M R Bristow, W W Parmley, et al.
Pageof 4